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How Much Sun Protection Is
Needed?: Are We on the Way
To Full-Spectrum Protection?
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The skin-damaging effects of the UV part of solar radiation are well known and
therefore are a focus of photobiological research. However, UVR is only a small
part of the solar radiation flux that reaches the earth’s surface. In this issue, Liebel
et al. shed light on the biological effects of visible solar radiation on human skin.
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For many years, the focus of photobiology
research and photo-protective strategies
has centered on the UV portion of the
solar spectrum of radiation. This is for a
good reason, since the high energy of UV
radiation induces acute and chronic skin
damage already after short time of expo-
sure. Therefore, current sunscreen products
are designed to provide high protection
in the UVB and UVA ranges of solar
radiation. However, only 5% of solar
radiation reaching the surface of the
earth is within the UV range, whereas
about 40–45% is visible light, andB50%
is in the longer-wavelength infrared (IR)
portion. Several groups have reported
skin damage due to IR-A radiation
(Schroeder et al., 2008; Zastrow et al.,
2009), but little attention has been paid
to visible light thus far. In this issue,
Liebel et al. (2012) report on oxidative
stress induced in human skin in response
to visible light. The authors found that
irradiation of skin cells with visible light,
in doses comparable to 15–90 minutes
of sunlight exposure, elicited a response
similar to that induced by UV radiation,
i.e., inflammation, ROS production, and
the release of matrix-degrading enzymes.
The division between UVA1 and visible
light is arbitrary
The historic division between UVA1 and
visible light is arbitrary, only determined
by the sensitivity of the human eye,
which is limited to wavelengths in the
solar spectrum that are consequently
defined as ‘‘visible’’. The study of effects
of visible light has been hampered in the
past by the lack of irradiation devices
delivering proper radiation between
400 and 780 nm without contamination
by UV radiation. However, the current
literature shows accumulating evidence
that visible light significantly impacts skin
physiology (Mahmoud et al., 2008;
Opla¨nder et al., 2011).
Visible light induces DNA damage
Direct damage of DNA by UVB radiation
mainly results from absorption of photons
by DNA bases. The ensuing DNA lesions
are either cyclobutane pyrimidine dimers
(CPD) or 6–4 photoproducts. Although
high UVA doses have been shown to
induce CPDs as well, most of the damage
occurs indirectly via ROS generated
by endogenous chromophores such as
flavins, porphyrins, and bilirubin. This
oxidative DNA damage results in base
modifications such as 8-oxo-guanosin.
Liebel et al. (2012) did not find any
thymine dimer formation following visi-
ble light irradiation; other forms of DNA
damage were not analyzed. However,
8-oxo-guanosin formation was found by
Kielbassa et al. (1997) after irradiation of
Chinese hamster cells with visible light.
Maximum DNA damage occurred bet-
ween 400 and 450nm. More research is
needed to investigate the exact contri-
bution of visible light to DNA damage,
as most of the earlier studies were carried
out with mixtures of UV and visible
radiation.
ROS, pro-inflammatory cytokines, and
MMP production are induced by visible
light
ROS are known to be the major media-
tors of oxidative damage in the skin.
Visible light, especially in the blue wave-
length range, has been used to treat
inflammatory skin diseases such as atopic
dermatitis and acne (Omi et al., 2004;
Becker et al., 2011). Oxidative stress most
likely contributes to the efficacy of these
treatments. Liebel et al. (2012) induced
dose dependently an increase in ROS
production with visible light similar to
that observed with UVA. However,
normal skin should be protected against
such ROS because of their acute
damaging effects and long-term contribu-
tions to premature skin aging. In fact,
today’s UV sunscreen filters do not pro-
vide any protection in the visible light
range. Filters for visible light inevitably
would be visible to the human eye, and
this would not be appreciated by sun-
screen users. Antioxidants therefore could
be a good alternative; consequently,
Liebel et al. tested the efficacy of anti-
oxidants in preventing visible light–
induced oxidative stress. In human skin
equivalents, UVB/UVA sunscreens plus
an antioxidant mixture strongly reduced
ROS, IL-1, and MMP-1 release after
irradiation with visible light, whereas
UVB/UVA sunscreens alone did not. This
is in line with a recent study by Haywood
et al. (2012), who used ESR/spin trapping
to monitor solar-simulated radiation-
induced ROS production in skin equi-
valents and found only partial protection
by conventional broad-spectrum sun-
screens. To establish the clinical rele-
vance of their in vitro findings, Liebel
et al. conducted a clinical study and con-
firmed free-radical production induced
by visible light and its reduction by anti-
oxidant treatment.
Exposure to visible light induces the
EGFR–ERK pathway
UVR is known to activate a plethora of
signal transduction pathways, leading to
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cellular reactions such as DNA repair,
growth inhibition, inflammation, and, in
the case of melanocytes, to increased
melanin production. Liebel et al. (2012)
analyzed signal transduction pathways and
found that visible light activates the EGFR–
ERK pathway. This activation of EGFR–ERK
has been demonstrated for UV irradiation
(Huang et al., 1996), and might explain the
expression of MMPs in response to visible
light, and it points toward a role for visible
light in premature skin aging. Given the
fact that many different molecules in
human skin absorb photons in the visible
wavelength range, it is unlikely that only
the EGFR–ERK pathway is activated. Here,
again, more research is needed to under-
stand the biological effects of visible light.
Conclusion
There is increasing evidence that visible
light can damage human skin. This effect
might seem negligible compared with
that of UV-induced skin damage; how-
ever, with sunscreen products providing
effective protection in the full UV range,
the remaining visible light might become
a more relevant source of sun-induced
oxidative stress. Liebel et al. (2012)
showed that sunscreens with effective
antioxidants might be a suitable means
of reducing visible light–induced ROS
and premature skin aging. Future
research is required to establish the
clinical relevance of these studies.
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Clinical Implications
 Visible light, especially in the blue light range, significantly impacts human
skin physiology.
 Sunscreens are designed to protect against UVR, but they do not block
visible light–induced reactive oxygen species (ROS); therefore, the
addition of antioxidants would provide additional protection against
oxidative stress.
 The overall contributions of visible light to oxidative stress reactions in
human skin induced by sunlight must be determined.
Double Trouble: Homozygous
Dominant Mutations and Hair Loss
in Pachyonychia Congenita
Alan D. Irvine1
In this issue, Wilson et al. report the first case of homozygous dominant negative
mutations in KRT17 in pachyonychia congenita (PC). Homozygous dominant
negative mutations are a rare occurrence in keratin disorders and this is a first
report in PC. These mutations cause a distinct sub-phenotype of PC that is more
severe in the offspring of affected parents and has associated alopecia.
Journal of Investigative Dermatology (2012) 132, 1757–1759. doi:10.1038/jid.2012.121
The age of gene discovery for Mendelian
genodermatoses can be said to have
started in 1987 with the identification of
deletions in STS in recessive X-linked
ichthyosis (Bonifas et al., 1987); there
then followed more than a decade and
a half of sustained, highly productive dis-
covery, driven by several energetic groups
and enabled by refined mapping tech-
niques and the Human Genome Mapping
Project (Irvine and McLean, 2003). Scien-
tific insights were plentiful as the identi-
fication of causative genes in single-gene
disorders revealed previously unknown
or unsuspected molecular pathways and
mechanisms of disease, some of which
have significant implications for common
complex disorders (Chavanas et al., 2000).
Rare and unheralded genoderma-
toses, heretofore, like carefully curated
museum specimens, smothered under
the cumbrance of Ancient Greek and
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